Terms: = Breast cancer AND ERCC3, RAD25, 2071, ENSG00000163161, GTF2H, TFIIH, BTF2, P19447, XPB
44 results:
1. Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in breast cancer Survivors on Aromatase Inhibitors.
Wagner MA; Koleck TA; Conway A; Bender CM; Conley YP
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002974
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trials.
Haussmann J; Budach W; Corradini S; Krug D; Jazmati D; Tamaskovics B; Bölke E; Pedotoa A; Kammers K; Matuschek C
Radiat Oncol; 2023 Nov; 18(1):181. PubMed ID: 37919752
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variability of oxidative stress and DNA repair genes associated with pre-treatment cancer-related fatigue in women with breast cancer.
Davis T; Koleck T; Conway A; Bender C; Conley Y
Support Care Cancer; 2023 May; 31(6):345. PubMed ID: 37212918
[TBL] [Abstract] [Full Text] [Related]
4. Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage breast cancer.
Zhao F; Miyashita M; Hattori M; Yoshimatsu T; Howard F; Kaneva K; Jones R; Bell JSK; Fleming GF; Jaskowiak N; Nanda R; Zheng Y; Huo D; Olopade OI
JAMA Netw Open; 2023 Mar; 6(3):e233329. PubMed ID: 36995716
[TBL] [Abstract] [Full Text] [Related]
5. Is complete pathological response truly a complete response in breast cancer?
Rehman B; Rehman S; Mohtasham S; Zahid T; Sarwar A; Parvaiz MA
J Pak Med Assoc; 2023 Feb; 73(2):280-283. PubMed ID: 36800710
[TBL] [Abstract] [Full Text] [Related]
6. Effect of breast Conservation Therapy vs Mastectomy on Overall Survival and breast cancer-Specific Survival Among Men With Stage I-II breast cancer: Analysis of SEER, 2000-2018.
He Y; Gao X; Wu J; Li X; Ma Z
Clin Breast Cancer; 2022 Jul; 22(5):410-417. PubMed ID: 35473920
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and characterization of a new spontaneously immortalized ER
Nobili S; Mannini A; Parenti A; Raggi C; Lapucci A; Chiorino G; Paccosi S; Di Gennaro P; Vezzosi V; Romagnoli P; Susini T; Coronnello M
Sci Rep; 2021 Apr; 11(1):8340. PubMed ID: 33863935
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort.
Liu Y; Wang H; Wang X; Liu J; Li J; Wang X; Zhang Y; Bai Z; Zhou Q; Wu Y; Shen Y; Weng X; Liu F; Guo J; Di L; Gires O; Zhang Z; Chen Y; Wang H
J Hematol Oncol; 2021 Jan; 14(1):18. PubMed ID: 33461583
[TBL] [Abstract] [Full Text] [Related]
9. ercc3, a new ovarian cancer susceptibility gene?
Stradella A; Del Valle J; Rofes P; Vargas-Parra G; Salinas M; González S; Montes E; López-Doriga A; Gómez C; de Cid R; Darder E; Teulé A; Solanes A; Munté E; Capellà G; Pineda M; Feliubadaló L; Brunet J; Lázaro C
Eur J Cancer; 2020 Dec; 141():1-8. PubMed ID: 33125943
[TBL] [Abstract] [Full Text] [Related]
10. Negative estrogen receptors and positive progesterone receptors breast cancers.
Delvallée J; Etienne C; Arbion F; Vildé A; Body G; Ouldamer L
J Gynecol Obstet Hum Reprod; 2021 Feb; 50(2):101928. PubMed ID: 33022450
[TBL] [Abstract] [Full Text] [Related]
11. Disruption of tfiih activities generates a stress gene expression response and reveals possible new targets against cancer.
Uriostegui-Arcos M; Aguayo-Ortiz R; Valencia-Morales MDP; Melchy-Pérez E; Rosenstein Y; Dominguez L; Zurita M
Open Biol; 2020 Jun; 10(6):200050. PubMed ID: 32543350
[TBL] [Abstract] [Full Text] [Related]
12. Contribution of Germline Predisposition Gene Mutations to breast cancer Risk in African American Women.
Palmer JR; Polley EC; Hu C; John EM; Haiman C; Hart SN; Gaudet M; Pal T; Anton-Culver H; Trentham-Dietz A; Bernstein L; Ambrosone CB; Bandera EV; Bertrand KA; Bethea TN; Gao C; Gnanaolivu RD; Huang H; Lee KY; LeMarchand L; Na J; Sandler DP; Shah PD; Yadav S; Yang W; Weitzel JN; Domchek SM; Goldgar DE; Nathanson KL; Kraft P; Yao S; Couch FJ
J Natl Cancer Inst; 2020 Dec; 112(12):1213-1221. PubMed ID: 32427313
[TBL] [Abstract] [Full Text] [Related]
13. Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.
Bonache S; Esteban I; Moles-Fernández A; Tenés A; Duran-Lozano L; Montalban G; Bach V; Carrasco E; Gadea N; López-Fernández A; Torres-Esquius S; Mancuso F; Caratú G; Vivancos A; Tuset N; Balmaña J; Gutiérrez-Enríquez S; Diez O
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2495-2513. PubMed ID: 30306255
[TBL] [Abstract] [Full Text] [Related]
14. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM
Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001
[TBL] [Abstract] [Full Text] [Related]
15. Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.
Tedaldi G; Tebaldi M; Zampiga V; Danesi R; Arcangeli V; Ravegnani M; Cangini I; Pirini F; Petracci E; Rocca A; Falcini F; Amadori D; Calistri D
Oncotarget; 2017 Jul; 8(29):47064-47075. PubMed ID: 28423363
[TBL] [Abstract] [Full Text] [Related]
16. WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness.
Payne C; Wiffen PJ; Martin S
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008427. PubMed ID: 28387447
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis].
Tao T; Yang JX; Shen K; Cao DY
Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):20-25. PubMed ID: 28190311
[No Abstract] [Full Text] [Related]
18. A Recurrent ercc3 Truncating Mutation Confers Moderate Risk for breast cancer.
Vijai J; Topka S; Villano D; Ravichandran V; Maxwell KN; Maria A; Thomas T; Gaddam P; Lincoln A; Kazzaz S; Wenz B; Carmi S; Schrader KA; Hart SN; Lipkin SM; Neuhausen SL; Walsh MF; Zhang L; Lejbkowicz F; Rennert H; Stadler ZK; Robson M; Weitzel JN; Domchek S; Daly MJ; Couch FJ; Nathanson KL; Norton L; Rennert G; Offit K
Cancer Discov; 2016 Nov; 6(11):1267-1275. PubMed ID: 27655433
[TBL] [Abstract] [Full Text] [Related]
19. Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.
Harrod A; Fulton J; Nguyen VTM; Periyasamy M; Ramos-Garcia L; Lai CF; Metodieva G; de Giorgio A; Williams RL; Santos DB; Gomez PJ; Lin ML; Metodiev MV; Stebbing J; Castellano L; Magnani L; Coombes RC; Buluwela L; Ali S
Oncogene; 2017 Apr; 36(16):2286-2296. PubMed ID: 27748765
[TBL] [Abstract] [Full Text] [Related]
20. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ercc3, ERCC4, ERCC5 and XPA.
Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
[TBL] [Abstract] [Full Text] [Related]
[Next]
